Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Taxus Cardium Pharmaceuticals Group (CRXM)

Taxus Cardium Pharmaceuticals Group (CRXM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Taxus Cardium Pharmaceuticals Group 11230 SORRENTO VALLEY RD. SUITE 220 SAN DIEGO CA 92121 USA

genebiotherapeutics.com P: 858-414-1477

Description:

Taxus Cardium Pharmaceuticals Group Inc. operates as a development stage advanced regenerative therapeutics company. It is focused on the late-stage clinical and commercial development of regenerative medicine therapeutics. The company provides Generx (R) for the treatment of cardiac microvascular insufficiency due to advancing coronary artery disease, and Excellagen (R), for the treatment of chronic non-healing diabetic foot, venous and pressure ulcers. Taxus Cardium Pharmaceuticals Group Inc., formerly known as Cardium Therapeutics, Inc., is headquartered in San Diego, California.

Key Statistics

Overview:

Market Capitalization, $K 1
Enterprise Value, $K -359
Shares Outstanding, K 14,490
Annual Sales, $ 0 K
Annual Net Income, $ -520 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -440 K
EBIT, $ -870 K
EBITDA, $ -860 K
% of Insider Shareholders 49.80%
% of Institutional Shareholders 0.00%
Float, K 7,274
% Float 50.20%

Growth:

1-Year Return 0.00%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 07/27/18
Earnings Per Share ttm 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

CRXM Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % 0.00%
Debt/Equity -0.01
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.32
Interest Coverage -9.83
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar